IL1B and periodontal disorder: Using antagonists of IL-1 receptors, some authors have proven the role of IL-1 in stimulating periapical bone destruction and thus pointed out significantly higher values of IL-1α in serum and gingival crevicular fluid in patients with periodontal disease compared to healthy ones [11].